Skip to content

Beta Blocker Use in Cardiac Surgery and Association With Postoperative Course

Use and Prescription of Beta-blockers Before Cardiac Surgery With Cardiopulmopnary Bypass: Multicenter Observational Analysis of Practices and Its Association With Postoperative Morbidity-mortality.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04769752
Acronym
BLOCK
Enrollment
1789
Registered
2021-02-24
Start date
2020-06-30
Completion date
2023-12-22
Last updated
2024-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Surgery With Cardiopulmonary Bypass

Brief summary

The objective of this study is to describe in a cohort of cardiac surgery patients the use of beta-blockers before surgery and their maintenance or withdraw according to international recommendations in order to compare patients who receive a beta-blocker with maintenance during the surgical period (international recommendation) to those for whom prescription and maintenance are not respected. Patients are treated according to standard practice and this protocol does not change patient management. No additional information or data is required by the study other than the data usually collected in the patient record (drug treatment, medical history, operating data, postoperative data, complications, length of stay). The objectives of this research are : * To evaluate the proportion of patients receiving beta-blocker treatment prior to cardiac surgery. * To evaluate the proportion of patients receiving beta-blocker treatment before cardiac surgery and complying with international recommendations for its maintenance/stop in perioperative cardiac surgery. * To evaluate the incidence of complications and length of hospital stay in patients receiving beta-blockers based on compliance or non-compliance with recommendations.

Interventions

OTHERcollection of the allocated treatment

collection of the allocated treatment

OTHERcollection of medical complications

collection of medical complications

Sponsors

Centre Hospitalier Universitaire Dijon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Major patient ≥ 18 years * Patient operated cardiac surgery with cardiopulmonary bypass * Patients who have given oral consent to participate after full information

Exclusion criteria

* Off pump cardiac surgery

Design outcomes

Primary

MeasureTime frameDescription
Number of patients treated with beta-blocker in accordance with international guidelines7 daysNumber of patients treated with beta-blocker in accordance with international guidelines

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026